Karuna Therapeutics, Inc. KRTX
329.83 +329.83
Day range unavailable
52-week range unavailable
KRTX revenue history
Revenue is income from the company’s ordinary business activities.
654,000 USD
FY 2023 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2023 | 2023-12-31 | 654,000 | -9,983,000 | -93.85% |
| FY 2022 | 2022-12-31 | 10,637,000 | -26,327,000 | -71.22% |
| FY 2021 | 2021-12-31 | 36,964,000 | 36,964,000 | Not meaningful |
| FY 2020 | 2020-12-31 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | 0 | Not meaningful |
| FY 2017 | 2017-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:03:20.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.